Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response

A. De Gassart*, K.S. Le, P. Brune, S. Agaugue, J. Sims, A. Goubard, R. Castellano, N. Joalland, E. Scotet, Y. Collette, E. Valentin, C. Ghigo, C. Pasero, M. Colazet, J. Guillen, C.E. Cano, A. Marabelle, J. De Bonno, R. Hoet, A. TrunehD. Olive, P. Frohna

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

INIS

Pharmacology, Toxicology and Pharmaceutical Science